A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma

Trial Profile

A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma

Discontinued
Phase of Trial: Phase II

Latest Information Update: 21 Apr 2017

At a glance

  • Drugs Vemurafenib (Primary) ; Acitretin
  • Indications Malignant melanoma
  • Focus Adverse reactions
  • Most Recent Events

    • 30 Mar 2016 Status changed from completed to discontinued as reported by ClinicalTrials.gov record.
    • 13 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 24 Sep 2014 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top